OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drops take aim at Glaucoma's silent threat
Disease control CompletedThis study tested two new eye drop formulas to see if they safely lower high eye pressure, a major risk factor for glaucoma. Over 400 adults with open-angle glaucoma or ocular hypertension used the drops for 7 or 28 days. Researchers compared the new drops to existing treatments …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Alcon Research • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New eye drop challenges standard glaucoma treatment in major trial
Disease control CompletedThis large, completed study compared a new investigational eye drop called NCX 470 to a standard medication (latanoprost) for treating open-angle glaucoma and ocular hypertension. The main goal was to see if the new drop was safe and effective at lowering high pressure inside the…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Nicox Ophthalmics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New eye drop shows promise for glaucoma in early trial
Disease control CompletedThis study tested a new eye drop called SBI-100 to see if it could safely lower high pressure inside the eye, which is a key factor in glaucoma. 56 adults with glaucoma or high eye pressure were randomly assigned to use one of two strengths of the eye drop or a placebo drop twice…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New eye implant aims to treat two conditions at once
Disease control CompletedThis study tested a single device that combines a new lens for cataract surgery with a slow-release implant for glaucoma. It involved 24 people who needed cataract surgery and also had mild-to-moderate glaucoma or high eye pressure. The main goal was to see if the device could sa…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New eye drop formula tested to fight leading cause of blindness
Disease control CompletedThis study tested two new strengths of an experimental eye drop called T4090 against an already approved drop, Rhopressa. The goal was to see if the new drops are as good or better at safely lowering high pressure inside the eye for people with glaucoma. About 161 adults with ope…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Mar 23, 2026 15:28 UTC